# Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial

> **NCT05758246** · PHASE2 · RECRUITING · sponsor: **University of Minnesota** · enrollment: 220 (estimated)

## Conditions studied

- Sepsis
- Acute Infection
- Organ Failure

## Interventions

- **DRUG:** Fisetin-dose 1
- **DRUG:** Fisetin-dose 2
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05758246
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-23
- **Primary completion:** 2026-08-23
- **Final completion:** 2026-08-23
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2025-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05758246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05758246, "Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05758246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*